China Physiotherapy Equipment Market Report 2023 to 2030

China Physiotherapy Equipment Market Analysis

$ 3999

The China Physiotherapy Equipment Market was valued at $1,680.09 Mn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $3,012.59 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are HMS Medical Systems, Wego Medical, WNQ, and Orient among others.

ID: IN10CNMD024 CATEGORY: Medical Devices GEOGRAPHY: China AUTHOR: Avantika Gupta

Buy Now

China Physiotherapy Equipment Market Executive Summary

The China Physiotherapy Equipment Market is at around $1,680.09 Mn in 2023 and is projected to reach $3,012.59 Mn in 2030, exhibiting a CAGR of 8.7% during the forecast period.

Physiotherapy equipment refers to the instruments that physiotherapists use to help cases recover from accidents, operations, or habitual conditions. These include exercise cycles, ultrasound machines, and resistance bands. The utilization of physiotherapy equipment can help reduce the level of care required for these patients.

Musculoskeletal conditions encompass a wide range of conditions and conditions affecting the muscles, bones, joints, and connective tissues, leading to pain, mobility limitations, and reduced functioning. These conditions include low reverse pain, neck pain, fractures, osteoarthritis, amputations, rheumatoid arthritis, and other musculoskeletal issues. Musculoskeletal diseases affect limited mobility and are a significant cause of disability. Furthermore, the rising prevalence of neurological disorders in the population is the primary driver behind the increasing demand for neurology rehabilitation physiotherapy equipment. The most commonly utilized physiotherapy interventions for elderly individuals with neurological disorders include balance and gait training, occupational therapy, traditional physiotherapy techniques, walking and treadmill exercises, and upper limb robot-assisted therapy.

The market therefore is driven by significant factors like the aging population, rising prevalence of cardiovascular, neurological, and musculoskeletal diseases, and advancements in technology play a key role in market growth. However, limited accessibility to specialized physiotherapists, high cost of physiotherapy equipment, and strict regulatory approval.

The leading pharmaceutical companies include HMS Medical Systems and Wego Medical for physiotherapy equipment. With continuous research and development activities, WNQ and Shua are also significant contributors to the physiotherapy equipment landscape.

China Physiotherapy Equipment Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Rise in Geriatric Population: China has a significantly large geriatric population, accounting for roughly 19.8% of the total population. Geriatric physiotherapy has acquired priority because elderly people suffer from several co-morbidities such as cardiovascular degeneration, visual impairment, hearing loss, diabetes, etc. Moreover, to reduce the degree of suffering, manufacturers are heavily investing in designing advanced physiotherapy equipment for the elderly. The incidence of age-related physical and psychological ailments is increasing in the coming years.

Increasing Technical Progress: Companies progressively focus on technological advancements and developing new goods to provide superior, user-friendly devices. The development of advanced physiotherapy equipment with enhanced capabilities, such as electrotherapy and cryotherapy devices, drives market growth by providing more effective treatment options.

Increased chronic diseases: The prevalence of chronic diseases like arthritis, cardiovascular diseases, neurological disorders, and musculoskeletal conditions is on the rise in China. The prevalence of arthritis specifically was 43.7% among older Chinese adults. Physiotherapy plays a crucial role in managing these conditions, driving the demand for equipment used in treatment plans.

Market Restraints

High Cost of Physiotherapy Equipment: Advanced physiotherapy equipments are expensive. Hospitals and clinics are hesitant to invest large sums, especially with uncertain reimbursement scenarios.

Regulatory Obstacles: Obtaining regulatory approvals for medical devices and equipment used in physiotherapy is a time-consuming and resource-intensive process, potentially delaying market entry and restricting the growth of physiotherapy equipment.

Competition from Alternative Therapies: Traditional Chinese medicine and other alternative therapies are well-established in China. Patients choose these options over physiotherapy, impacting the market growth of related equipment.

Regulatory Landscape and Reimbursement Scenario

The regulatory landscape for medical devices in China is overseen by the National Medical Products Administration (NMPA). The primary legislation is the Regulations on the Supervision and Administration of Medical Devices (2021). This document outlines the classification, registration, and overall management of medical devices in China. Devices are categorized into three classes based on risk level, Class I (Low Risk), Class II (Medium Risk), and Class III (High Risk). The complexity of registration varies depending on the class. Class I devices have a faster filing process, while Class II and III involve a more rigorous registration process.

Currently, physiotherapy services in China often have limited or unclear coverage under public health insurance. This can be a significant barrier for patients seeking physiotherapy treatment. The Chinese government promotes private healthcare insurance by offering tax incentives.

Competitive Landscape

Key Players

Here are some of the major key players in the China Physiotherapy Equipment Market:

Shua
HMS Medical Systems
Wego Medical
ITO Co. Ltd
Enraf-Nonius B.V.
WNQ
Orient
Shinva Medical
DJO Global
Zynex Medical Inc.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

China Physiotherapy Equipment Market Segmentation

By Equipment

Hydrotherapy
Electrotherapy
Cryotherapy
Continuous Passive Motion Units
Multi-exercise Therapy Unit
Heat Therapy
Shockwave Therapy
Laser Therapy
Traction Therapy
Ultrasound
Other Equipment Types

By Application

Cardiovascular and Pulmonary
Neurological
Musculoskeletal
Paediatric
Other Applications

By End User

Hospitals
Physiotherapy & Rehabilitation Centers
Home Care Settings

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.